This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you something about systems behind the document. A certificate that is a number and a signature tells you less.
Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth documenting.
Coming back to post #32, because the follow-up matters more than the original answer.
Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming implausible perfection without backing evidence is overreaching.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
I read post #36 twice before replying, because I had assumed the opposite.
Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
post #38 answers the question as asked. The question underneath it is different.
Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices without justification raise different flags.
On post #36 — agreed on the reasoning, with one qualification.
Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not glamorous but it is foundational.
Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming implausible perfection without backing evidence is overreaching.
Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices without justification raise different flags.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
Picking up post #41: that is the part I would want checked first.
Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not glamorous but it is foundational.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
post #49 answers the question as asked. The question underneath it is different.
Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth documenting.
Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and legitimacy.
Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you something about systems behind the document. A certificate that is a number and a signature tells you less.
post #52 answers the question as asked. The question underneath it is different.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
On post #50 — agreed on the reasoning, with one qualification.
Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same product, is a red flag for either incompetence or deception.
Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
I read post #54 twice before replying, because I had assumed the opposite.
Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices without justification raise different flags.
post #56 is right about the mechanism and I think understates the practical bit.
Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming implausible perfection without backing evidence is overreaching.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.